 MIchael Franklin
Concepts (371)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas aeruginosa | 32 | 2026 | 395 | 6.550 |
Why?
| | Biofilms | 26 | 2026 | 292 | 4.820 |
Why?
| | Gene Expression Regulation, Bacterial | 17 | 2026 | 337 | 2.520 |
Why?
| | Bacterial Proteins | 23 | 2026 | 967 | 2.330 |
Why?
| | Ribosomes | 5 | 2026 | 193 | 2.160 |
Why?
| | Ribosomal Proteins | 3 | 2020 | 93 | 1.650 |
Why?
| | Alginates | 11 | 2012 | 60 | 1.150 |
Why?
| | Calcium | 7 | 2025 | 1190 | 0.910 |
Why?
| | Anti-Bacterial Agents | 7 | 2026 | 1923 | 0.890 |
Why?
| | Drug Resistance, Bacterial | 6 | 2026 | 185 | 0.760 |
Why?
| | Regulon | 1 | 2023 | 34 | 0.750 |
Why?
| | Ciprofloxacin | 6 | 2026 | 31 | 0.740 |
Why?
| | Virulence Factors | 4 | 2016 | 174 | 0.730 |
Why?
| | Tobramycin | 4 | 2026 | 63 | 0.660 |
Why?
| | DNA, Bacterial | 5 | 2018 | 320 | 0.660 |
Why?
| | Hibernation | 2 | 2020 | 82 | 0.620 |
Why?
| | Poaceae | 1 | 2019 | 37 | 0.600 |
Why?
| | Sigma Factor | 4 | 2023 | 47 | 0.570 |
Why?
| | Hexuronic Acids | 6 | 2005 | 29 | 0.490 |
Why?
| | Bacteria | 4 | 2020 | 765 | 0.460 |
Why?
| | Microbiological Techniques | 1 | 2015 | 30 | 0.450 |
Why?
| | Homeostasis | 2 | 2016 | 642 | 0.440 |
Why?
| | Ecosystem | 1 | 2019 | 478 | 0.440 |
Why?
| | Virulence | 4 | 2026 | 278 | 0.420 |
Why?
| | Siderophores | 1 | 2013 | 13 | 0.390 |
Why?
| | Ferredoxins | 1 | 2013 | 11 | 0.390 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2013 | 23 | 0.390 |
Why?
| | Carbohydrate Epimerases | 4 | 2005 | 5 | 0.390 |
Why?
| | Sulfates | 1 | 2013 | 45 | 0.390 |
Why?
| | Gene Regulatory Networks | 1 | 2016 | 317 | 0.390 |
Why?
| | Glucuronic Acid | 5 | 2005 | 30 | 0.380 |
Why?
| | Achievement | 1 | 2013 | 58 | 0.380 |
Why?
| | Bacterial Physiological Phenomena | 2 | 2015 | 47 | 0.370 |
Why?
| | Pseudomonas putida | 1 | 2013 | 44 | 0.360 |
Why?
| | Awards and Prizes | 1 | 2013 | 71 | 0.360 |
Why?
| | Pyridines | 2 | 2013 | 609 | 0.340 |
Why?
| | Research Personnel | 1 | 2013 | 184 | 0.340 |
Why?
| | Pseudomonas Infections | 5 | 2016 | 230 | 0.330 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2010 | 507 | 0.330 |
Why?
| | Genes, Bacterial | 4 | 2013 | 152 | 0.320 |
Why?
| | Gene Transfer, Horizontal | 2 | 2014 | 34 | 0.320 |
Why?
| | DNA, Ribosomal | 1 | 2010 | 84 | 0.310 |
Why?
| | Microbial Viability | 2 | 2026 | 83 | 0.300 |
Why?
| | Multigene Family | 4 | 2004 | 210 | 0.300 |
Why?
| | RNA, Messenger | 4 | 2018 | 2803 | 0.290 |
Why?
| | RNA, Ribosomal | 2 | 2020 | 168 | 0.270 |
Why?
| | Ligases | 2 | 2026 | 38 | 0.270 |
Why?
| | Acetyltransferases | 2 | 2001 | 27 | 0.260 |
Why?
| | Operon | 2 | 2018 | 67 | 0.260 |
Why?
| | Scientific Misconduct | 1 | 2006 | 7 | 0.240 |
Why?
| | Genetic Complementation Test | 6 | 2013 | 72 | 0.240 |
Why?
| | Peer Review | 1 | 2006 | 47 | 0.230 |
Why?
| | Mythology | 1 | 2005 | 4 | 0.230 |
Why?
| | Polymyxin B | 1 | 2025 | 21 | 0.230 |
Why?
| | Pseudoalteromonas | 1 | 2005 | 1 | 0.230 |
Why?
| | Gene Knockout Techniques | 2 | 2018 | 119 | 0.230 |
Why?
| | Ethics, Medical | 1 | 2006 | 90 | 0.230 |
Why?
| | Rare Diseases | 1 | 2026 | 116 | 0.230 |
Why?
| | Protons | 2 | 2004 | 96 | 0.220 |
Why?
| | Proton-Translocating ATPases | 1 | 2004 | 5 | 0.220 |
Why?
| | Sequence Alignment | 3 | 2020 | 362 | 0.210 |
Why?
| | Conflict of Interest | 1 | 2005 | 54 | 0.210 |
Why?
| | Molecular Sequence Data | 10 | 2014 | 2883 | 0.210 |
Why?
| | Confidentiality | 1 | 2005 | 80 | 0.210 |
Why?
| | Commerce | 1 | 2005 | 80 | 0.210 |
Why?
| | Ion Channel Gating | 1 | 2004 | 94 | 0.200 |
Why?
| | Escherichia coli | 3 | 2019 | 835 | 0.200 |
Why?
| | Publishing | 1 | 2005 | 114 | 0.200 |
Why?
| | Amino Acid Sequence | 8 | 2014 | 2129 | 0.190 |
Why?
| | Terminology as Topic | 1 | 2005 | 257 | 0.190 |
Why?
| | Arabinose | 1 | 2023 | 5 | 0.190 |
Why?
| | Models, Chemical | 1 | 2004 | 250 | 0.190 |
Why?
| | Microscopy, Confocal | 5 | 2014 | 319 | 0.190 |
Why?
| | Aminoglycosides | 1 | 2023 | 30 | 0.190 |
Why?
| | Stress, Physiological | 3 | 2019 | 443 | 0.190 |
Why?
| | Proteome | 1 | 2007 | 514 | 0.190 |
Why?
| | Acetylation | 5 | 2004 | 259 | 0.180 |
Why?
| | Liposomes | 1 | 2004 | 262 | 0.180 |
Why?
| | Periodicals as Topic | 1 | 2005 | 209 | 0.180 |
Why?
| | Heat-Shock Proteins | 1 | 2023 | 139 | 0.180 |
Why?
| | Gene Deletion | 4 | 2016 | 391 | 0.180 |
Why?
| | Oxygen | 4 | 2019 | 978 | 0.170 |
Why?
| | Genomics | 1 | 2026 | 825 | 0.160 |
Why?
| | Extracellular Matrix | 1 | 2005 | 562 | 0.160 |
Why?
| | Evolution, Molecular | 1 | 2004 | 492 | 0.160 |
Why?
| | Mutation | 5 | 2020 | 4075 | 0.160 |
Why?
| | Protein Stability | 1 | 2020 | 176 | 0.160 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2020 | 376 | 0.150 |
Why?
| | Models, Molecular | 2 | 2020 | 1598 | 0.150 |
Why?
| | Enterobacteriaceae | 1 | 2019 | 44 | 0.140 |
Why?
| | DNA Transposable Elements | 3 | 2016 | 124 | 0.140 |
Why?
| | Rivers | 1 | 2019 | 62 | 0.140 |
Why?
| | RNA, Bacterial | 3 | 2010 | 182 | 0.140 |
Why?
| | Genes, Reporter | 3 | 2008 | 277 | 0.140 |
Why?
| | Polysaccharides, Bacterial | 2 | 2001 | 69 | 0.140 |
Why?
| | Mutagenesis, Insertional | 3 | 2016 | 67 | 0.140 |
Why?
| | Transcription, Genetic | 2 | 2023 | 1454 | 0.130 |
Why?
| | Metagenomics | 1 | 2019 | 149 | 0.130 |
Why?
| | Pyrroles | 2 | 2010 | 220 | 0.130 |
Why?
| | Neoplasm Metastasis | 2 | 2010 | 688 | 0.130 |
Why?
| | Gene Expression Profiling | 3 | 2016 | 1767 | 0.130 |
Why?
| | Fat Body | 1 | 2016 | 9 | 0.130 |
Why?
| | Fluorescent Dyes | 1 | 2018 | 333 | 0.120 |
Why?
| | Algorithms | 1 | 2004 | 1845 | 0.120 |
Why?
| | Uronic Acids | 2 | 2003 | 3 | 0.120 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2015 | 32 | 0.110 |
Why?
| | Drosophila | 1 | 2016 | 164 | 0.110 |
Why?
| | Lung Neoplasms | 4 | 2015 | 2664 | 0.110 |
Why?
| | Minnesota | 2 | 2006 | 168 | 0.110 |
Why?
| | Longevity | 1 | 2016 | 178 | 0.110 |
Why?
| | Wound Infection | 1 | 2016 | 60 | 0.110 |
Why?
| | Oligonucleotides, Antisense | 1 | 2015 | 118 | 0.110 |
Why?
| | Indoles | 2 | 2010 | 507 | 0.110 |
Why?
| | Haloferax volcanii | 1 | 2014 | 1 | 0.110 |
Why?
| | Genetic Variation | 2 | 2011 | 972 | 0.110 |
Why?
| | EF Hand Motifs | 1 | 2014 | 3 | 0.110 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2016 | 199 | 0.110 |
Why?
| | Microbial Interactions | 1 | 2014 | 18 | 0.100 |
Why?
| | Amino Acid Motifs | 2 | 2005 | 219 | 0.100 |
Why?
| | RNA, Small Interfering | 1 | 2016 | 637 | 0.100 |
Why?
| | Food Deprivation | 1 | 2014 | 28 | 0.100 |
Why?
| | Biosensing Techniques | 1 | 2016 | 142 | 0.100 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1246 | 0.100 |
Why?
| | Protein Structure, Secondary | 2 | 2005 | 371 | 0.100 |
Why?
| | Quorum Sensing | 2 | 2015 | 80 | 0.100 |
Why?
| | Escherichia coli O157 | 1 | 2013 | 14 | 0.100 |
Why?
| | Societies, Scientific | 1 | 2013 | 50 | 0.100 |
Why?
| | Calcium-Binding Proteins | 1 | 2014 | 221 | 0.090 |
Why?
| | Cell Membrane Permeability | 2 | 2013 | 88 | 0.090 |
Why?
| | Molecular Targeted Therapy | 1 | 2015 | 439 | 0.090 |
Why?
| | Bile Acids and Salts | 1 | 2013 | 163 | 0.090 |
Why?
| | Gels | 1 | 2012 | 85 | 0.090 |
Why?
| | Drosophila melanogaster | 1 | 2014 | 237 | 0.090 |
Why?
| | Green Fluorescent Proteins | 3 | 2008 | 407 | 0.090 |
Why?
| | Pyocyanine | 2 | 2014 | 5 | 0.080 |
Why?
| | Iron | 1 | 2013 | 357 | 0.080 |
Why?
| | Energy Metabolism | 1 | 2017 | 935 | 0.080 |
Why?
| | Cystic Fibrosis | 3 | 2011 | 1161 | 0.080 |
Why?
| | Microdissection | 1 | 2010 | 13 | 0.080 |
Why?
| | Adamantinoma | 1 | 2010 | 4 | 0.080 |
Why?
| | Benzenesulfonates | 1 | 2010 | 23 | 0.080 |
Why?
| | Pericytes | 1 | 2010 | 42 | 0.080 |
Why?
| | Acinetobacter Infections | 1 | 2009 | 15 | 0.070 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 627 | 0.070 |
Why?
| | Carcinoma, Neuroendocrine | 1 | 2010 | 36 | 0.070 |
Why?
| | Acinetobacter baumannii | 1 | 2009 | 26 | 0.070 |
Why?
| | Transcriptome | 1 | 2016 | 1038 | 0.070 |
Why?
| | Genome, Bacterial | 1 | 2010 | 123 | 0.070 |
Why?
| | Photochemotherapy | 1 | 2009 | 39 | 0.070 |
Why?
| | Photosensitizing Agents | 1 | 2009 | 42 | 0.070 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 2 | 2001 | 85 | 0.070 |
Why?
| | Neovascularization, Pathologic | 1 | 2010 | 286 | 0.070 |
Why?
| | Nucleic Acid Probes | 1 | 2008 | 2 | 0.070 |
Why?
| | Exopeptidases | 1 | 2008 | 2 | 0.070 |
Why?
| | Silver | 1 | 2008 | 36 | 0.070 |
Why?
| | Chlorine | 1 | 2008 | 59 | 0.070 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2010 | 122 | 0.070 |
Why?
| | Protein Structure, Tertiary | 2 | 2014 | 855 | 0.070 |
Why?
| | Neuroendocrine Tumors | 1 | 2010 | 119 | 0.070 |
Why?
| | Cryoultramicrotomy | 1 | 2008 | 7 | 0.070 |
Why?
| | Microradiography | 1 | 2008 | 2 | 0.070 |
Why?
| | Antineoplastic Agents | 2 | 2010 | 2214 | 0.070 |
Why?
| | Autoradiography | 1 | 2008 | 66 | 0.070 |
Why?
| | Disinfectants | 1 | 2008 | 45 | 0.070 |
Why?
| | Klippel-Trenaunay-Weber Syndrome | 1 | 2008 | 5 | 0.070 |
Why?
| | Skin Ulcer | 1 | 2008 | 15 | 0.070 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2005 | 196 | 0.070 |
Why?
| | Histological Techniques | 1 | 2008 | 39 | 0.070 |
Why?
| | Humans | 20 | 2026 | 145475 | 0.070 |
Why?
| | Lasers | 1 | 2008 | 126 | 0.060 |
Why?
| | Skin Neoplasms | 2 | 2011 | 849 | 0.060 |
Why?
| | Cytosol | 1 | 2007 | 213 | 0.060 |
Why?
| | Hydrogen Peroxide | 1 | 2008 | 335 | 0.060 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2008 | 325 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2015 | 2028 | 0.060 |
Why?
| | Phylogeny | 3 | 2011 | 917 | 0.060 |
Why?
| | Species Specificity | 1 | 2007 | 546 | 0.060 |
Why?
| | Animals | 8 | 2016 | 38030 | 0.060 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2004 | 531 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2016 | 4560 | 0.060 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 1189 | 0.060 |
Why?
| | Diffusion | 2 | 2019 | 120 | 0.060 |
Why?
| | Automation | 1 | 2026 | 104 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 977 | 0.060 |
Why?
| | Plankton | 2 | 2022 | 8 | 0.060 |
Why?
| | History, 18th Century | 1 | 2005 | 18 | 0.060 |
Why?
| | Calcium Chloride | 1 | 2005 | 10 | 0.060 |
Why?
| | Base Sequence | 4 | 2001 | 2170 | 0.060 |
Why?
| | Osmotic Pressure | 2 | 2016 | 41 | 0.060 |
Why?
| | Thyroid Neoplasms | 1 | 2010 | 350 | 0.060 |
Why?
| | Phenazines | 1 | 2005 | 17 | 0.060 |
Why?
| | Consensus Sequence | 1 | 2005 | 73 | 0.060 |
Why?
| | Metalloendopeptidases | 1 | 2005 | 63 | 0.060 |
Why?
| | Endopeptidases | 1 | 2005 | 80 | 0.060 |
Why?
| | Extracellular Fluid | 1 | 2004 | 38 | 0.050 |
Why?
| | Sequence Analysis, DNA | 3 | 2001 | 777 | 0.050 |
Why?
| | Lung Diseases | 1 | 2011 | 780 | 0.050 |
Why?
| | Quality Control | 1 | 2005 | 161 | 0.050 |
Why?
| | Electric Conductivity | 1 | 2004 | 85 | 0.050 |
Why?
| | Myelin Proteolipid Protein | 1 | 2004 | 61 | 0.050 |
Why?
| | Sequence Homology | 1 | 2004 | 43 | 0.050 |
Why?
| | Serine Endopeptidases | 1 | 2005 | 128 | 0.050 |
Why?
| | Gram-Positive Bacteria | 1 | 2004 | 48 | 0.050 |
Why?
| | DNA-Binding Proteins | 1 | 2011 | 1480 | 0.050 |
Why?
| | Oxidation-Reduction | 1 | 2008 | 1067 | 0.050 |
Why?
| | Burns | 1 | 2009 | 374 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2011 | 2158 | 0.050 |
Why?
| | Gram-Negative Bacteria | 1 | 2004 | 80 | 0.050 |
Why?
| | Mutagenesis | 2 | 1996 | 194 | 0.050 |
Why?
| | Adaptation, Physiological | 1 | 2008 | 560 | 0.050 |
Why?
| | Conserved Sequence | 1 | 2004 | 244 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 3 | 2003 | 387 | 0.050 |
Why?
| | Phosphotransferases (Phosphomutases) | 1 | 2003 | 6 | 0.050 |
Why?
| | Signal Transduction | 1 | 2016 | 5216 | 0.050 |
Why?
| | Periplasm | 1 | 2002 | 13 | 0.050 |
Why?
| | Pseudomonas fluorescens | 1 | 2001 | 3 | 0.040 |
Why?
| | Immunocompromised Host | 1 | 2003 | 202 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2014 | 749 | 0.040 |
Why?
| | Research | 1 | 2005 | 430 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2014 | 2597 | 0.040 |
Why?
| | Carbon | 1 | 2022 | 176 | 0.040 |
Why?
| | Software | 1 | 2026 | 680 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2001 | 79 | 0.040 |
Why?
| | Ampicillin | 1 | 2000 | 16 | 0.040 |
Why?
| | Klebsiella pneumoniae | 1 | 2000 | 47 | 0.040 |
Why?
| | Mediastinal Neoplasms | 2 | 2010 | 53 | 0.040 |
Why?
| | Montana | 1 | 2019 | 18 | 0.040 |
Why?
| | Serogroup | 1 | 2019 | 45 | 0.040 |
Why?
| | Water Quality | 1 | 2019 | 35 | 0.040 |
Why?
| | Phenotype | 4 | 2011 | 3155 | 0.040 |
Why?
| | Cell Membrane | 1 | 2002 | 707 | 0.030 |
Why?
| | Biological Transport | 2 | 2015 | 424 | 0.030 |
Why?
| | Neutrophils | 1 | 2003 | 1124 | 0.030 |
Why?
| | Staphylococcus aureus | 1 | 2022 | 451 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2004 | 1164 | 0.030 |
Why?
| | Bacterial Infections | 1 | 2020 | 246 | 0.030 |
Why?
| | Angiogenesis Inhibitors | 2 | 2010 | 238 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2010 | 2382 | 0.030 |
Why?
| | Argonaute Proteins | 1 | 2016 | 32 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2005 | 3413 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 2004 | 1368 | 0.030 |
Why?
| | Methanococcus | 1 | 1996 | 10 | 0.030 |
Why?
| | Rats | 1 | 2005 | 5584 | 0.030 |
Why?
| | Apoptosis | 1 | 2004 | 2440 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2010 | 1716 | 0.030 |
Why?
| | Osteopontin | 1 | 2015 | 35 | 0.030 |
Why?
| | Pyrophosphatases | 1 | 2015 | 26 | 0.030 |
Why?
| | Drosophila Proteins | 1 | 2016 | 213 | 0.030 |
Why?
| | Neoplasms | 1 | 2010 | 2906 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1476 | 0.030 |
Why?
| | Metabolic Flux Analysis | 1 | 2014 | 8 | 0.030 |
Why?
| | Isomerism | 1 | 1994 | 56 | 0.030 |
Why?
| | Plant Diseases | 1 | 2014 | 44 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2015 | 247 | 0.030 |
Why?
| | Cell Compartmentation | 1 | 1994 | 52 | 0.030 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2014 | 57 | 0.030 |
Why?
| | Deoxycytidine | 1 | 2015 | 220 | 0.030 |
Why?
| | Genomic Islands | 1 | 2013 | 10 | 0.030 |
Why?
| | DNA Damage | 1 | 2016 | 437 | 0.030 |
Why?
| | Flagella | 1 | 2013 | 27 | 0.020 |
Why?
| | Ploidies | 1 | 1993 | 20 | 0.020 |
Why?
| | Spectrophotometry, Infrared | 1 | 1993 | 53 | 0.020 |
Why?
| | Protein Precursors | 1 | 1994 | 136 | 0.020 |
Why?
| | Survival Analysis | 1 | 2016 | 1374 | 0.020 |
Why?
| | Random Allocation | 1 | 2014 | 365 | 0.020 |
Why?
| | Metabolic Networks and Pathways | 1 | 2014 | 174 | 0.020 |
Why?
| | Wound Healing | 1 | 2016 | 355 | 0.020 |
Why?
| | Mice | 4 | 2016 | 18329 | 0.020 |
Why?
| | Anaerobiosis | 2 | 2004 | 65 | 0.020 |
Why?
| | Chemotaxis | 1 | 2013 | 122 | 0.020 |
Why?
| | Bacterial Adhesion | 1 | 2013 | 108 | 0.020 |
Why?
| | Culture Media | 2 | 2004 | 161 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2015 | 552 | 0.020 |
Why?
| | Biopolymers | 1 | 2012 | 35 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 1993 | 506 | 0.020 |
Why?
| | Models, Biological | 1 | 2019 | 1764 | 0.020 |
Why?
| | Prognosis | 2 | 2011 | 4316 | 0.020 |
Why?
| | X-ray Repair Cross Complementing Protein 1 | 1 | 2011 | 14 | 0.020 |
Why?
| | Polymers | 1 | 1996 | 485 | 0.020 |
Why?
| | Escherichia coli Proteins | 1 | 2013 | 201 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2013 | 337 | 0.020 |
Why?
| | Down-Regulation | 1 | 2013 | 618 | 0.020 |
Why?
| | Angiogenic Proteins | 1 | 2010 | 15 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 847 | 0.020 |
Why?
| | Stromal Cells | 1 | 2010 | 121 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 2010 | 200 | 0.020 |
Why?
| | Male | 6 | 2016 | 72843 | 0.020 |
Why?
| | Porphyrins | 1 | 2009 | 16 | 0.020 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2010 | 80 | 0.020 |
Why?
| | Polyethyleneimine | 1 | 2009 | 19 | 0.020 |
Why?
| | Schistosomiasis | 1 | 2010 | 50 | 0.020 |
Why?
| | Dimethyl Sulfoxide | 1 | 2009 | 42 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 2 | 2010 | 2769 | 0.020 |
Why?
| | Extracellular Matrix Proteins | 1 | 2010 | 156 | 0.020 |
Why?
| | Phenylurea Compounds | 1 | 2010 | 119 | 0.020 |
Why?
| | Niacinamide | 1 | 2010 | 104 | 0.020 |
Why?
| | Foot | 1 | 2010 | 103 | 0.020 |
Why?
| | Colony Count, Microbial | 1 | 2008 | 89 | 0.020 |
Why?
| | Psoriasis | 1 | 2010 | 115 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2010 | 331 | 0.020 |
Why?
| | Female | 6 | 2016 | 78845 | 0.020 |
Why?
| | Soft Tissue Neoplasms | 1 | 2010 | 131 | 0.020 |
Why?
| | Accidents, Traffic | 1 | 2010 | 193 | 0.020 |
Why?
| | Staining and Labeling | 1 | 2008 | 153 | 0.020 |
Why?
| | Protein Binding | 1 | 2014 | 2238 | 0.020 |
Why?
| | Positron-Emission Tomography | 1 | 2010 | 343 | 0.020 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2010 | 231 | 0.020 |
Why?
| | Appendicitis | 1 | 2010 | 150 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2015 | 2507 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2014 | 1356 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 3542 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 2010 | 441 | 0.020 |
Why?
| | Bone Neoplasms | 1 | 2010 | 259 | 0.020 |
Why?
| | United States | 1 | 2005 | 16098 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 1261 | 0.020 |
Why?
| | Genotype | 1 | 2011 | 1852 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2010 | 820 | 0.010 |
Why?
| | Chronic Disease | 1 | 2011 | 1808 | 0.010 |
Why?
| | Mice, Neurologic Mutants | 1 | 2004 | 21 | 0.010 |
Why?
| | Spermatogonia | 1 | 2004 | 16 | 0.010 |
Why?
| | Carbenicillin | 1 | 2004 | 1 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2008 | 1162 | 0.010 |
Why?
| | Fractures, Bone | 1 | 2010 | 428 | 0.010 |
Why?
| | Bioreactors | 1 | 2004 | 50 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2010 | 874 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2004 | 414 | 0.010 |
Why?
| | Respiratory Burst | 1 | 2003 | 19 | 0.010 |
Why?
| | Caspase 3 | 1 | 2004 | 242 | 0.010 |
Why?
| | Mesoderm | 1 | 2004 | 147 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2011 | 3623 | 0.010 |
Why?
| | Caspases | 1 | 2004 | 233 | 0.010 |
Why?
| | Cytoplasmic Granules | 1 | 2003 | 60 | 0.010 |
Why?
| | Glass | 1 | 2003 | 46 | 0.010 |
Why?
| | Plastics | 1 | 2003 | 50 | 0.010 |
Why?
| | Carbohydrate Sequence | 1 | 2003 | 29 | 0.010 |
Why?
| | Biomarkers, Tumor | 1 | 2010 | 1321 | 0.010 |
Why?
| | Stereoisomerism | 1 | 2003 | 103 | 0.010 |
Why?
| | Opportunistic Infections | 1 | 2003 | 47 | 0.010 |
Why?
| | Smoking | 1 | 2010 | 1472 | 0.010 |
Why?
| | Cell Separation | 1 | 2003 | 305 | 0.010 |
Why?
| | Central Nervous System | 1 | 2004 | 282 | 0.010 |
Why?
| | Trophoblasts | 1 | 2004 | 218 | 0.010 |
Why?
| | Gene Order | 1 | 2001 | 29 | 0.010 |
Why?
| | Phagocytosis | 1 | 2003 | 296 | 0.010 |
Why?
| | Lung | 1 | 2014 | 4106 | 0.010 |
Why?
| | Immunoblotting | 1 | 2001 | 295 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2001 | 538 | 0.010 |
Why?
| | Penicillin Resistance | 1 | 2000 | 9 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2003 | 718 | 0.010 |
Why?
| | Drug Resistance, Microbial | 1 | 2000 | 64 | 0.010 |
Why?
| | Penicillins | 1 | 2000 | 62 | 0.010 |
Why?
| | Cell Division | 1 | 2001 | 756 | 0.010 |
Why?
| | Permeability | 1 | 2000 | 169 | 0.010 |
Why?
| | Drug Stability | 1 | 2000 | 169 | 0.010 |
Why?
| | Skin | 1 | 2004 | 753 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2004 | 2188 | 0.010 |
Why?
| | Microbial Sensitivity Tests | 1 | 2000 | 364 | 0.010 |
Why?
| | Anti-Infective Agents | 1 | 2000 | 232 | 0.010 |
Why?
| | Immunity, Innate | 1 | 2003 | 835 | 0.010 |
Why?
| | Middle Aged | 2 | 2010 | 36215 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 8333 | 0.010 |
Why?
| | Infant | 1 | 2011 | 10077 | 0.010 |
Why?
| | Risk Factors | 1 | 2011 | 10885 | 0.010 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 1996 | 45 | 0.010 |
Why?
| | Child, Preschool | 1 | 2011 | 11853 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 1996 | 187 | 0.010 |
Why?
| | Adult | 2 | 2010 | 40777 | 0.010 |
Why?
| | Young Adult | 1 | 2011 | 14219 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2008 | 11772 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 22530 | 0.010 |
Why?
| | Child | 1 | 2011 | 22707 | 0.010 |
Why?
|
|
Franklin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|